Kevin Parker

Fellow

Leaders In Tech

Jan 2023 - Jan 2024 (1 year 1 month)

Co-Founder, CEO

Cartography Biosciences

Dec 2020 - Current (5 years 9 months)

Cartography is building precision antibody therapeutics for cancer. We've lacked the tools to build precise immunotherapies because we've lacked precise antigens to target – Cartography is creating the roadmap of antigen expression and building safer and more effective therapeutics.

CEO, Co-Founder

Cartography Biosciences

Dec 2020 - Current (5 years 9 months)

Cartography Biosciences is advancing a differentiated oncology pipeline of antibody-based therapies designed to target tumors more precisely than existing therapeutics. Cartography’s ATLAS and SUMMIT drug discovery platforms are powered by an industry-leading, fully integrated dataset spanning hundreds of thousands of cell states across the healthy body and large-scale profiling of individual cells from patient tumors. By leveraging petabytes of proprietary data, along with insights from machine learning and AI, Cartography is discovering antibodies against highly specific targets and target pairs to build a pipeline of molecules with the greatest patient impact. Cartography’s lead program CBI-1214, is a T-cell engager for CRC.

Teaching

Stanford University

Sep 2017 - Dec 2018 (1 year 4 months)

Developed an introductory bioinformatics curriculum, and was a teaching assistant in STEMREM 201A and STEMREM201B, courses for incoming PhD students in the stem cell program at Stanford.

Graduate Student, Chang Lab

Stanford University

Sep 2016 - Dec 2020 (4 years 4 months)

PhD research at Stanford in Howard Chang's lab, working in functional genomics, computational biology, and immunology. Research projects were directed at understanding immunotherapy response, as it relates to antigen expression and CAR-T phenotype, as well as developing novel single-cell and genomic assays to understand how the genome is regulated.

Course Assistant, SCRB 10

Harvard University

Sep 2015 - Dec 2015 (4 months)

Undergraduate Thesis Research, Eggan lab

Harvard University

Sep 2013 - May 2016 (2 years 9 months)

Undergraduate thesis research working in the lab of Professor Kevin Eggan in the Department of Stem Cell and Regenerative Biology. Studied the development of three populations of hypothalamic neurons using in vitro and in vivo models.

About

Detail

Timeline

Résumé